Acne Treatment Market to Record Robust Compound Annual Growth Rate During the Forecast Period 2025

10/giu/2020 10:19:37 persistencemarketresearch Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

New York City, United States -- Since the COVID-19 infection flare-up in December 2019, the malady has spread to right around 100 nations around the world with the World Health Organization proclaiming it a general wellbeing crisis. The worldwide effects of the coronavirus sickness 2019 (COVID-19) are now beginning to be felt, and will essentially influence the Healthcare Industry in 2020.

 

The average age of onset of acne has reduced from 14-15 years to 11-12 years due to changing demographics and social habits. Moreover, some of the misleading media content continue to encourage the habit of self-medication that often backfires, resulting in further complication.

Over the past couple of years, demand for acne treatment drugs and medications has surged at a remarkable pace. After conducting an exclusive study, Persistence Market Research (PMR) identified that approximately 20% of the young population (aged below 13 years) suffer from moderate-to-severe acne issues.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/5279

Company Profiles

  • Alma Lasers Ltd.
  • Lumenis Ltd.
  • Cutera, Inc.
  • Stiefel Laboratories Inc.
  • Galderma S.A.
  • Valeant Pharmaceutical International, Inc.
  • Verilux, Inc.
  • Johnson and Johnson
  • Syneron Medical Ltd
  • Allergan plc.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/5279

According to the PMR study, the global acne treatment market was pegged at US$ 4,920 Mn in 2016. This market is expected to reach US$ 7,348 Mn by the end of 2025, reflecting a CAGR of 4.6% over the forecast period (2017– 2025).

Drug makers are implementing better testing methods. Many of the active ingredients for manufacturing acne treatment medicines are used only if they are clinically evidenced and have satisfactory documented outcomes. Alma Lasers Ltd., Lumenis Ltd., Cutera, Inc, Stiefel Laboratories Inc., Galderma S.A., Verilux, Inc., Valeant Pharmaceutical International, Inc. , Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Allergan Plc., and Syneron Medical Ltd are some of top medical companies that operate in the global acne treatment market.

Many of these market players are actively focusing on expanding distribution base to emerging countries in order to improve their overall market presence. As a matter of fact, growing medical tourism in developing countries is expected to create potential market opportunities in the near future.

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl